What is the Early Access to Medicines Scheme (EAMS)?
Introduced in 2014, EAMS aims to give patients with life-threatening or seriously debilitating conditions access to medicines when there is a clear unmet need. The scheme is voluntary and does not replace the normal licensing procedures.
Read more on MAP website: https://www.mappatientaccess.com/blog/?post=early-access-to-medicines-scheme
OpenEdition vous propose de citer ce billet de la manière suivante :
egennet (17 mai 2022). What is the Early Access to Medicines Scheme (EAMS)? ELSIBI. Consulté le 7 octobre 2026 à l’adresse https://doi.org/10.58079/o5zb
